Related Experiment Video
Updated: Jun 4, 2026
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Psoriasis induced by cetuximab: a paradoxical adverse effect
Albert Mas-Vidal1, Pablo Coto-Segura, Cristina Galache-Osuna
1Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain. albert.mas.vidal@gmail.com
Abstract:
Cetuximab, an epidermal growth factor receptor inhibitor, is a chemotherapeutical agent featuring well-known adverse dermatological effects related to tumour-response prognosis. In psoriasis, the epidermal growth factor receptor is overexpressed; hence, the expectation would be that an epidermal growth factor receptor inhibitor could improve psoriatic lesions. We report a case of psoriasis induced by cetuximab, which was a surprising adverse effect.